AMD announced its first life sciences collaboration with AI-based drug developer Absci, providing its hardware and software for Absci’s AI drug discovery. Despite AMD also investing $20m in Absci, its shares fell 4% after HSBC analyst Frank Lee downgraded the firm from “Buy” to “Reduce” and cut its price target by 18%, suggesting AMD will continue trailing market leader Nvidia. This is AMD’s first life-sciences partnership.
Hackers Hammer Android and iPhone Users As Bank Account Attacks Surge 258% in One Year: Kaspersky
The number of smartphone users affected by banking malware soared 258% in 2024, according to cybersecurity firm Kaspersky. The most prolific malware was Mamont, which
